TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve In furtherance to our earlier communication dated 6th May, 2022 with respect to intimation of the date of the Board meeting scheduled to be held on 25th May, 2022, we would like to inform that the Board of Directors in the said meeting would also consider the proposal for issuance of Bonus shares to the shareholders of the Company.